U.S. Markets for Orthopedic Extremity and Soft Tissue Repair

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair

  • September 2015 •
  • Report ID: 3384794
The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury. Innovation in the treatment of bone, joint, and soft tissue of the extremities will primarily be seen in biologics, as new products are designed harnessing cellular therapies, such as stem cells, to regrow and restore damaged bone and tissue.

Markets covered by this report include reconstructive extremity products (Chapter 1), soft tissue repair products (Chapter 2), fracture fixation products (Chapter 3), and biologic and synthetic orthopedic extremity repair products (Chapter 4).

Topics covered in this report include:

procedure and market forecasts for the years 2014 to 2019;
key factors influencing the growth of individual product markets;
estimated market shares and sales among major U.S. suppliers;
major supplier product portfolio analysis in individual product markets; and,
emerging technology that could potentially change the way orthopedic extremities and soft tissue are repaired, which could potentially change how product markets develop.
Over the forecast period covered in this report, the estimated value of the U.S. market for orthopedic extremity and soft tissue repair products is expected to grow by approximately $2,203.9 million at a compound annual growth rate (CAGR) of 12.6%. Reconstructive extremity products will grow at a CAGR of 11.7%, soft tissue repair products at a CAGR of 9.9%, fracture fixation products at a CAGR of 14.2%, and biologic and synthetic orthopedic extremity repair products at a CAGR of 19.8%.

Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.